“…First of all, a reliable methodology of ADC value measurement should be developed and uniformed between the future studies. Currently, some authors perform a direct measurement of ADC value [7,18,20,21], while the others calculate the relative ADC value [10,19], referring it to an unaffected bone, for instance, in the midline of the sacral bone [10]. Additionally, in some reports, there is a comparison between ADC value within the inflammatory lesions and to the one measured within the unaffected bone [7,10,18,20,21], while in the others, mean ADC value from regions unaffected by bone marrow oedema or structural changes is globally assessed and compared between the sides and the groups with and without axSpA [19].…”